Home Trending Stocks Eloxx Pharmaceuticals, Inc. (ELOX) stock gains during pre-market session. Here’s to know...

Eloxx Pharmaceuticals, Inc. (ELOX) stock gains during pre-market session. Here’s to know why?

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) stock gained by 2.92% at last close while the ELOX stock price rises by 2.84% in the pre-market trading. Eloxx Pharmaceuticals is working on developing novel Ribosome Modulating Agents (RMAs) using its groundbreaking TURBO-ZMTM chemistry technology platform and its library of Eukaryotic Ribsome Selective Glycosides (ERSGs).

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What is happening?

ELOX on May 18, 2021, announced the successful completion of an underwritten public offering of 38,333,334 shares of common stock at a price of $1.35 per share. The underwriters’ option to buy an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions, was fully exercised at the closing. After subtracting underwriting discounts and fees, as well as sale costs, the total proceeds from the offering is roughly $51.75 million.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

The offering is being managed by B. Riley Securities, Inc. as the sole bookrunner.

Financial Results

On May 7, 2021, Eloxx Pharmaceuticals announced its first-quarter 2021 financial results. Given below is the summary.

  • ELOX had a net loss of $8.7 million, or $0.22 per share, for the three months ending March 31, 2021, which included $1.3 million in stock-based compensation. ELOX had a net loss of $13.9 million, or $0.35 per share, in the same timeframe last year
  • For the three months ending March 31, 2021, ELOX research and development costs totaled $4.1 million, including $0.2 million in stock-based compensation. R&D costs were $4.8 million in the same timeframe the previous year. Reduced expenditures relating to the creation of ELX-02 as a result of the COVID-19 and realignment measures taken in February 2020, which included increases in R&D headcount and external investment, drove the decline in R&D expenses.
  • For the three months ending March 31, 2021, ELOX’s general and administrative costs were $4.3 million, including $1.1 million in stock-based compensation. G&A costs were $5.0 million in the same timeframe last year. Realignment measures initiated in February 2020, which included changes in general and executive headcount as well as external expenditures, were largely responsible for the decline.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

  • ELOX had $18.2 million in cash and cash equivalents as of March 31, 2021, which they believe to be enough to finance the activities into the third quarter of 2021.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

Energous Corporation Inc. (WATT) stock declines during after-market. Here’s to know why?

Energous Corporation Inc. (WATT) stock gained by 7.05% at last close whereas the WATT stock price plunged by 7.82% in the after-hours trading session....

AMAZON Inc. (AMZN) stock fell during after-market. Here’s the update

Amazon Inc. (NASDAQ: AMZN) stock plunged by 0.84% at last close however moving ahead the AMZAN share price also declines by 7.44% in the...

Cocrystal Pharma Inc. (COCP) stock soars during current market. Here’s what you should know

Cocrystal Pharma Inc. (NASDAQ: COCP) stock gains by 17.44% in the current market trading session. Cocrystal Pharma, Inc. is a clinical-stage biotechnology firm focused...

Best Inc. (BEST) stock gains during current market. Here’s the update?

Best Inc. (NASDAQ: BEST) stock rises by 5.45% during the current market. BEST Inc. is a prominent Chinese supplier of comprehensive smart supply chain...

Dolphin Entertainment Inc. (DLPN) stock rises during current market. Let’s find out why?

Dolphin Entertainment Inc. (NASDAQ: DLPN) stock gains by 17.47% to $9.21 today in the current market trading. Dolphin Entertainment is a leading independent entertainment...

General Electric Company Inc. (GE) stock sky-rocketing during pre-market. Here’s what you should know

General Electric Company Inc. (NASDAQ: GE) stock plunged by 2.56% at last close whereas the GE stock price surged massively during pre-market by 704.32%....

Related News

IT Tech Packaging Inc. (ITP) stock gains during pre-market. Here’s what’s happening?

IT Tech Packaging Inc. (NASDAQ: ITP) stock gained by 7.53% at last close while the ITP stock price rises by 2.04% in the pre-market...

Why did The9 Limited (NCTY) stock turnaround in the after-hours on Friday?

The9 Limited (NCTY) shares gained 6.87% in after-hours on Friday, July 30, 2021, and closed the weekly trading at $11.98 per share. in the...

Energous Corporation Inc. (WATT) stock declines during after-market. Here’s to know why?

Energous Corporation Inc. (WATT) stock gained by 7.05% at last close whereas the WATT stock price plunged by 7.82% in the after-hours trading session....

AMAZON Inc. (AMZN) stock fell during after-market. Here’s the update

Amazon Inc. (NASDAQ: AMZN) stock plunged by 0.84% at last close however moving ahead the AMZAN share price also declines by 7.44% in the...

Cocrystal Pharma Inc. (COCP) stock soars during current market. Here’s what you should know

Cocrystal Pharma Inc. (NASDAQ: COCP) stock gains by 17.44% in the current market trading session. Cocrystal Pharma, Inc. is a clinical-stage biotechnology firm focused...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam